These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8730730)

  • 1. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro.
    Anderson R; Feldman C; Theron AJ; Ramafi G; Cole PJ; Wilson R
    Br J Pharmacol; 1996 Apr; 117(7):1387-94. PubMed ID: 8730730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
    Anderson R; Ramafi G; Theron AJ
    Biochem Pharmacol; 1996 Jul; 52(2):341-9. PubMed ID: 8694859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
    Anderson R; Theron AJ; Feldman C
    Inflammation; 1996 Dec; 20(6):693-705. PubMed ID: 8979156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism.
    Mokgobu I; Theron AJ; Anderson R; Feldman C
    Int J Immunopharmacol; 1999 Jun; 21(6):365-77. PubMed ID: 10405872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.
    Ullman A; Bergendal A; Lindén A; Waldeck B; Skoogh BE; Löfdahl CG
    Allergy; 1992 Aug; 47(4 Pt 2):384-7. PubMed ID: 1360770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
    Anderson GP
    Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P; Lötvall J; Lindén A
    Lung; 1996; 174(3):159-70. PubMed ID: 8830192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and -independent mechanisms.
    Mirza ZN; Kato M; Kimura H; Tachibana A; Fujiu T; Suzuki M; Mochizuki H; Tokuyama K; Morikawa A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):494-500. PubMed ID: 12027071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
    Baker AJ; Palmer J; Johnson M; Fuller RW
    Eur J Pharmacol; 1994 Nov; 264(3):301-6. PubMed ID: 7698169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.
    Anderson R; Theron AJ; Steel HC; Durandt C; Tintinger GR; Feldman C
    Mediators Inflamm; 2014; 2014():105420. PubMed ID: 24733958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
    Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
    Nials AT; Coleman RA; Johnson M; Vardey CJ
    Br J Pharmacol; 1997 Mar; 120(5):961-7. PubMed ID: 9138705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
    Spring J; Johnston SR; Seale J; Ind PW
    Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
    Chong LK; Cooper E; Vardey CJ; Peachell PT
    Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
    Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
    Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.